CVS Health Corporation
CVS
$61.54
-$2.12-3.33%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 12.00% | 10.54% | 10.13% | 10.81% | 9.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.00% | 10.54% | 10.13% | 10.81% | 9.56% |
| Cost of Revenue | 14.22% | 12.43% | 12.79% | 13.35% | 11.18% |
| Gross Profit | 0.53% | 0.82% | -2.78% | -1.40% | 1.89% |
| SG&A Expenses | 3.76% | 1.78% | 5.77% | 2.75% | -0.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.93% | 11.10% | 11.94% | 11.99% | 9.60% |
| Operating Income | -7.95% | -1.76% | -20.14% | -11.30% | 8.70% |
| Income Before Tax | -14.13% | 167.93% | -37.76% | -4.07% | 100.64% |
| Income Tax Expenses | -19.56% | 172.15% | -39.82% | 14.09% | 198.54% |
| Earnings from Continuing Operations | -12.22% | 166.64% | -37.02% | -9.04% | 79.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -150.00% | 42.86% | -30.00% | -500.00% | -80.00% |
| Net Income | -12.34% | 166.38% | -37.24% | -9.26% | 78.71% |
| EBIT | -7.95% | -1.76% | -20.14% | -11.30% | 8.70% |
| EBITDA | -4.31% | 0.30% | -15.86% | -9.88% | 4.99% |
| EPS Basic | -10.84% | 167.83% | -35.77% | -7.21% | 80.35% |
| Normalized Basic EPS | -11.49% | -1.83% | -20.32% | -6.62% | 11.36% |
| EPS Diluted | -10.47% | 167.56% | -35.37% | -6.78% | 81.76% |
| Normalized Diluted EPS | -11.23% | -2.06% | -20.09% | -6.06% | 11.78% |
| Average Basic Shares Outstanding | -1.68% | -2.13% | -2.28% | -2.21% | -0.91% |
| Average Diluted Shares Outstanding | -1.97% | -1.90% | -2.57% | -2.79% | -1.27% |
| Dividend Per Share | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% |
| Payout Ratio | 0.24% | 2.62% | 0.71% | 0.19% | -0.39% |
